Revenue and dividend growth alongside accumulation signals suggest that these stocks could be worth a spot in an income-oriented portfolio.
Learn how President Trump plans to lower drug prices and why it has minimal impact on pharma companies. Discover three top-performing pharma stocks.
Pfizer and UnitedHealth look like solid plays thanks to above average earnings growth and reasonable valuations, according to one market watcher.
Big pharma stocks are making a come back this year on innovations, new drugs, and other positive trends.